FINAL Addressing Societal Challenges Through Advancing the ...

1 downloads 178 Views 219KB Size Report
Research Applications of Nuclear and Radiation Technology. 20 – 21 March 2018, Charlemagne, Brussels. Conference Agend
FINAL Addressing Societal Challenges Through Advancing the Medical, Industrial and Research Applications of Nuclear and Radiation Technology 20 – 21 March 2018, Charlemagne, Brussels Conference Agenda

20 MARCH 2018 09:00 – 10:00

Registration

10:00 – 11:10 Opening Session Chair: Gerassimos Thomas, Deputy Director General, DG ENER Miguel Arias Cañete, European Commissioner for Climate Action and Energy Vytenis Andriukaitis, European Commissioner for Health and Food Safety Yukiya Amano, IAEA Director General Maria Neira, Director Public Health, Environment and Social Determinants, World Health Organisation

11:10 – 11:40

Coffee

11.40 – 13:10 SESSION 1 - Health: Ensuring security of supply of medical radioisotopes to deliver diagnosis and treatment Chair: Marian O'Leary, Director General, Euratom Supply Agency Introductory remarks: Kevin Charlton, OECD NEA Introductory remarks: Andre Kolmayer, NucAdvisor Panel Discussion: Richard Zimmerman (AIPES), Kristoff Muylle (EANM), Roy Brown (Curium); Sally W. Schwarz (SNMMI).

13:10 – 14:15

Lunch

14:15 – 15:45 SESSION 2 - Health: Novel nuclear medicine to advance patient care Chair: John Ryan, Director, DG SANTE Session opening: Vladimir Šucha, Director General, DG JRC Introductory remarks: Stefano Buono, Advisor to Advance Accelerator Applications Introductory remarks: Julien Dodet, CEO Orano Med Introductory remarks: Kristoff Muylle, President of the European Association of Nuclear Medicine Panel Discussion: Sally W. Schwarz (SNMMI), Francesco Giammarile (IAEA), Riccardo Schiavo (EMA), Paul M. Parizel (ESR), Marianne Patt (EANM Radiopharmacy), Maria Betti (JRC).

15:45 - 16.15

Coffee

16:15 – 17:45 SESSION 3 - Quality and safety: improving medical practice Chair: Carlo Pettinelli, Director, DG Grow Session opening: John Ryan, Director, DG SANTE Introductory remarks: Dominique Le Guludec, President, High Authority of Health, France Introductory remarks: Yolande Lievens, President of the European Society for Radiotherapy and Oncology Introductory remarks: Paul M. Parizel (European Society of Radiology – ESR); Panel Discussion: Sakari Karjalainen (European Cancer League), Lionel Hadjadjeba (COCIR), Sandra Gomez (French Hospital Federation), Mette Øhlenschlaeger (HERCA).

18:00

Drinks reception

2

21 MARCH 2018 09:00 – 10:30 SESSION 4 - Quality and Safety: challenges for the management of non-energy radioactive waste and spent fuel Chair: Massimo Garribba, Director, DG ENER Session opening: Michèle Rivasi, Member of the European Parliament Introductory remarks: Fabien Hubert, Head of Service Solutions for Non-Electronuclear Producers, ANDRA, France Introductory remarks: Andrej Stritar, Director, Slovenian Nuclear Safety Administration. Introductory remarks: Michalis Tzortzis, Radiation Inspection and Control Service, Cyprus Panel Discussion: Gerard Bruno (IAEA), Johan Swahn (Nuclear Transparency Watch, Sweden), Andreas Vesely (Austrian Nuclear Engineering Seibersdorf).

10:30 – 11:00

Coffee

11:00 – 12:30 SESSION 5 - Innovation: the potential of nuclear and radiation technology to deliver societal benefits in the future Chair: Charlina Vitcheva, Deputy Director General, DG JRC Session opening: Patrick Child, Deputy Director General, DG RTD Introductory remarks: Europe

Angeles Faus-Golfe, Applications of Particle Accelerators in

Introductory remarks: Winfried Petry, Scientific Director of the Research Neutron Source Heinz Maier-Leibnitz Panel Discussion: Caterina Petrillo (Perugia University), Erik Briers (Patient Advisory Group of ESR), Maurizio Vretenar (CERN/Eucard2), Luca Cozzi (COCIR).

12:30 – 13:30 CLOSING SESSION - Towards a Strategic Agenda for Medical, Industrial, and Research Applications of Nuclear and Radiation Technology Open Discussion Summary and next steps Closing remarks: Gerassimos Thomas, Deputy Director General, DG ENER

13:30

Lunch

3